Cargando…
A feasibility study of the Nativis Voyager(®) device in patients with recurrent glioblastoma in Australia
AIM: Evaluation of the Nativis Voyager(®), an investigational medical device, as monotherapy for recurrent glioblastoma (rGBM). MATERIALS & METHODS: A total of 15 patients with rGBM were treated with one of two Voyager ultra-low radio frequency energy cognates: A1A or A2HU. Safety and clinical u...
Autores principales: | Murphy, Michael, Dowling, Anthony, Thien, Christopher, Priest, Emma, Morgan Murray, Donna, Kesari, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499017/ https://www.ncbi.nlm.nih.gov/pubmed/30727742 http://dx.doi.org/10.2217/cns-2018-0017 |
Ejemplares similares
-
An early feasibility study of the Nativis Voyager(®) device in patients with recurrent glioblastoma: first cohort in US
por: Cobbs, Charles, et al.
Publicado: (2018) -
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma
por: Barkhoudarian, Garni, et al.
Publicado: (2023) -
126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID)
por: Shankar, Sripriya Nannu, et al.
Publicado: (2023) -
Breast cancer in previously thyroidectomized patients: which thyroid disorders are a risk factor?
por: Graceffa, Giuseppa, et al.
Publicado: (2021) -
A study of prisms and therapy in attention loss after stroke
(SPATIAL): A feasibility randomised controlled trial
por: Longley, Verity, et al.
Publicado: (2022)